Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Cognitive Dysfunction × Radiotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 20 Head and Neck Neoplasms 15 Prostatic Neoplasms 12 Neoplasms 12 Lung Neoplasms 11 Radiation Injuries 8 Esophageal Neoplasms 8 Glioma 6 Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Rectal Neoplasms 5 Glioblastoma 5 Neoplasm Metastasis 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Central Nervous System Neoplasms 3 Astrocytoma 3 Xerostomia 2 Urinary Bladder Neoplasms 2 Small Cell Lung Carcinoma 2 Salivary Gland Neoplasms 2 Pelvic Neoplasms 2 Osteoradionecrosis 2 Esthesioneuroblastoma, Olfactory 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Adenocarcinoma 2 Vulvar Neoplasms 1

Interventions

Neuropsychological Tests 4 Patient Reported Outcome Measures 2 Surveys and Questionnaires 1 Radiotherapy 1 Radiosurgery 1 Quality of Life 1 Mental Status and Dementia Tests 1 Interviews as Topic 1 Hematologic Tests 1 Functional Residual Capacity 1 Electroencephalography 1 Echocardiography 1 Drug Therapy 1 Drug Delivery Systems 1 Data Collection 1 Climate Anxiety 1 Chemoradiotherapy 1 Blood Specimen Collection 1 Absorptiometry, Photon 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06551857 2025-04-16

CaSPiN

Turku University Hospital

Ototoxicity, Neoplasms, Hearing Loss, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡